An Open-Label Phase I Dose Escalation Trial To Evaluate The Safety And Pharmacokinetics Of Motexafin Gadolinium And Doxorubicin Chemotherapy In The Treatment Of Advanced Malignancies

Trial Profile

An Open-Label Phase I Dose Escalation Trial To Evaluate The Safety And Pharmacokinetics Of Motexafin Gadolinium And Doxorubicin Chemotherapy In The Treatment Of Advanced Malignancies

Completed
Phase of Trial: Phase I

Latest Information Update: 29 Oct 2016

At a glance

  • Drugs Doxorubicin (Primary) ; Motexafin gadolinium (Primary)
  • Indications Advanced breast cancer; Colorectal cancer; Head and neck cancer; Leukaemia; Lung cancer; Lymphoma; Multiple myeloma; Myelodysplastic syndromes; Myeloproliferative disorders; Prostate cancer; Solid tumours
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 21 Aug 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top